CorWave logo — CorWave develops and manufactures innovative implantable blo...

CorWave

CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology.

Founded 2012 France France 97 employees Series C Total: $100.40M Health Care, Manufacturing +1

General Information

Company Name CorWave
Founded Year 2012
Location France France
Founders / Decision Makers
Team member Team member
Employees 97
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with CorWave. To contact CorWave, visit corwave.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CorWave compare?

A PDF of CorWave and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CorWave soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

In The News Sep 28, 2026

Featured on Tech: Sofinnova Partners closes oversubscribed €82M Sofinnova MD Start IV fund

About CorWave

CorWave is a French startup that focuses on developing innovative implantable blood pumps based on a breakthrough membrane technology. The company's wave membrane pump, which operates physiologically to mimic a pulse and blood flow rates similar to those of a healthy heart, sets it apart from commercially available left ventricular assist devices (LVADs). This innovative technology is expected to reduce complications associated with current devices and improve the management of heart failure patients. Founded in 2012 and headquartered in France, CorWave has garnered significant attention and support. It is a member of the French Tech 120 and has secured over €80 million in equity. The company currently employs over seventy people. In its most recent funding round, CorWave raised €26.00M in a Series C investment on 20 June 2023, with notable investors including Bpifrance, Vlerick Group, and EXOR N.V.

Business keywords: Implantable medical devices, Cardiac assist devices, Medical technology, Biomedical engineering, Ventricular assist devices, Membrane pump technology, Biomedical innovation, Heart failure management, Pulsatile blood flow, Investment, Equity financing, Start-up funding, Wireless energy transfer, Biomedical research

Services & Products

Developing innovative implantable blood pumps based on breakthrough membrane technology for cardiac support.

Target Customers

Patients with advanced heart failure in need of reliable and sustainable heart assist pumps.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series C €26.00M 3
Bpifrance, Vlerick Group +1
20 Jun 2023
Venture Round Undisclosed 1
European Innovation Council
19 Dec 2022
Series C €35.00M 8
Novo Holdings, Bpifrance +6
06 Jan 2021
Grant €2.50M 1
European Innovation Council
08 Jan 2020
Series C $16.50M -
10 Jul 2018
Series B $17.10M 5
Novo Holdings, Bpifrance +3
04 Nov 2016
Series A €3.30M 1
Gerard Hascoet
10 Jul 2013
Seed Round Undisclosed 1
AGORANOV
01 Jun 2012

CorWave Alternatives & Competitors

View All Alternatives
CorWave vs
V-Wave
V-Wave Israel

Advancing the flow of life

Series C
68 employees
Biotechnology, Health Care
CorWave vs
Cameron Health
Cameron Health United States

Cameron Health is a medical device developer based in San Clemente, California, USA. Cameron Health...

Series F
30 employees
Biotechnology, Health Care
CorWave vs

AI Cardiac Remote Monitoring

Venture round
128 employees
AI, Health Care

FAQ About CorWave

CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology.
CorWave was founded in 2012.
CorWave is headquartered in France.
CorWave operates in Health Care, Manufacturing and Medical Devices. Its work centres on Implantable medical devices, Cardiac assist devices, Medical technology and Biomedical engineering. Its customers include Patients with advanced heart failure in need of reliable and sustainable heart assist pumps..
CorWave has approximately 97 employees.
CorWave has completed 8 funding rounds, raising a total of $100.40M. The latest funding stage is Series C.
CorWave offers: Developing innovative implantable blood pumps based on breakthrough membrane technology for cardiac support..
Top alternatives and competitors to CorWave include V-Wave, Cameron Health, Implicity, Puzzle Medical Devices Inc., Magenta Medical Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CorWave and V-Wave are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CorWave, https://bouncewatch.com/company/corwave, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes